Details for New Drug Application (NDA): 211732
The generic ingredient in OMEPRAZOLE MAGNESIUM is omeprazole magnesium. There is one drug master file entry for this compound. Sixty-one suppliers are listed for this compound. Additional details are available on the omeprazole magnesium profile page.
Summary for 211732
| Tradename: | OMEPRAZOLE MAGNESIUM |
| Applicant: | Hetero Labs Ltd Iii |
| Ingredient: | omeprazole magnesium |
| Patents: | 0 |
Pharmacology for NDA: 211732
| Mechanism of Action | Cytochrome P450 2C19 Inhibitors Proton Pump Inhibitors |
Suppliers and Packaging for NDA: 211732
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| OMEPRAZOLE MAGNESIUM | omeprazole magnesium | TABLET, DELAYED RELEASE;ORAL | 211732 | ANDA | A-S Medication Solutions | 50090-6888 | 50090-6888-0 | 2 BOTTLE in 1 CARTON (50090-6888-0) / 14 TABLET, DELAYED RELEASE in 1 BOTTLE |
| OMEPRAZOLE MAGNESIUM | omeprazole magnesium | TABLET, DELAYED RELEASE;ORAL | 211732 | ANDA | Allegiant Health | 69168-476 | 69168-476-14 | 1 BOTTLE in 1 CARTON (69168-476-14) / 14 TABLET, DELAYED RELEASE in 1 BOTTLE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | OTC | Dosage: | TABLET, DELAYED RELEASE;ORAL | Strength | EQ 20MG BASE | ||||
| Approval Date: | Mar 25, 2020 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
